Agustin Gago
Corporate Officer/Principal bij Syncromune, Inc.
Vermogen: - $ op 30-04-2024
Profiel
Agustin V.
Gago is the founder of Dash International LLC, which was founded in 2013.
He is currently the Chief Business Officer at Syncromune, Inc. since 2020.
Mr. Gago's former positions include Director at Voyageur Pharmaceuticals Ltd., Vice President-Global GI Business Unit at E-Z-EM, Inc. from 1998 to 2008, Vice President-International IRE Sales at AngioDynamics, Inc. from 2008 to 2010, Executive Vice President-Global Sales at Delcath Systems, Inc. from 2009 to 2013, Chief Commercial Officer & Executive VP at InspireMD, Inc. from 2016 to 2018, and Chief Business Officer at ImmunSYS, Inc. from 2019 to 2020.
Mr. Gago received his undergraduate degree from Hofstra University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-04-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Agustin Gago
| Bedrijven | Functie | Begin |
|---|---|---|
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Corporate Officer/Principal | 01-01-2020 |
Eerdere bekende functies van Agustin Gago
| Bedrijven | Functie | Einde |
|---|---|---|
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Corporate Officer/Principal | 01-01-2020 |
| INSPIREMD, INC. | Corporate Officer/Principal | 30-09-2018 |
| DELCATH SYSTEMS, INC. | Verkoop & Marketing | 08-04-2013 |
E-Z-EM, Inc.
 E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Corporate Officer/Principal | 01-01-2008 |
| VOYAGEUR PHARMACEUTICALS LTD. | Directeur/Bestuurslid | - |
Opleiding van Agustin Gago
| Hofstra University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ANGIODYNAMICS, INC. | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| INSPIREMD, INC. | Health Technology |
| VOYAGEUR PHARMACEUTICALS LTD. | Process Industries |
| Bedrijven in privébezit | 4 |
|---|---|
E-Z-EM, Inc.
E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Health Technology |
Dash International LLC
 Dash International LLC Miscellaneous Commercial ServicesCommercial Services Dash International LLC provides business support services. The private company is based in Stevensville. The American company was founded by Agustin V. Gago. | Commercial Services |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
